Готові списки джерел за темами / Patients adherence

Зміст

Статті в журналах
Дисертації
Книги
Частини книг
Тези доповідей конференцій
Звіти організацій

Добірка наукової літератури з теми "Patients adherence"

Автор: Grafiati

Опубліковано: 11 березня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Patients adherence".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Patients adherence"

Zyryanov, Sergey K., Sergey B. Fitilev, Alexander V. Vozzhaev, Irina I. Shkrebniova, Natalya N. Shindryaeva, Dmitry A. Klyuev, Liusine N. Stepanyan, Nikolay N. Landyshev, and Yana G. Voronko. "Medication adherence in patients with stable coronary artery disease in primary care." Research Results in Pharmacology 6, no. 2 (June 30, 2020): 97–103. http://dx.doi.org/10.3897/rrpharmacology.6.54130.

Повний текст джерела

Анотація:

Introduction: Lack of research targeting non-adherence to cardiovascular medications in Russia prevents from developing effective interventions to improve adherence. The aim was to study medication adherence in patients with stable coronary artery disease in primary care. Material and methods: The study was conducted in a primary care setting of Moscow. Demography, medical history, pharmacotherapy data were obtained retrospectively from 386 coronary patients’ medical records. Medication adherence was measured by 8-item Morisky Medication Adherence Scale (MMAS-8). A statistical analysis was performed using SPSS Statistics V16.0. Results and discussion: According to the results from MMAS-8, 188 (48.7%) coronary patients had high medication adherence, 135 (35.0%) – moderate, and 63 (16.3%) – low. By the dichotomous interpretation: 48.7% (n = 188) – were adherent, 51.3% (n = 198) – were non-adherent. These groups were similar in gender distribution, age, and medical history profile (p > 0.1 for all variables). Smokers prevailed in the non-adherent group (13.6 vs. 5.3%; p = 0.009). Both groups were equally prescribed beta-blockers, antiplatelets, and statins (p > 0.1 for all). Use of fixed dose combinations (11.7 vs. 5.6%; p = 0.048) and the number of pills taken (mean 5.64 ± 1.52 vs. 5.99 ± 1.62; p = 0.029) were associated with better adherence. Higher values of total cholesterol (mean 5.2 ± 1.4 vs. 4.7 ± 1.2 mmol/L; p < 0.001) and low-density lipoprotein cholesterol (mean 2.9 ± 1.2 vs. 2.4 ± 0.9 mmol/L; p < 0.001) were revealed in non-adherents. Subjects with suboptimal adherence visited general practitioners more frequently (median 5 vs. 3 visits; p = 0,003). Conclusion: Medication non-adherence in coronary outpatients exceeded 50%. High adherence was associated with more frequent use of fixed dose combinations and fewer pills taken by patient. Smoking and poorer control of blood lipids prevailed in non-adherents, who also caused higher load on general practitioners.

Стилі APA, Harvard, Vancouver, ISO та ін.

Algarni, Majed A., Meznah S. Althobiti, Sarah A. Alghamdi, Huriyyah A. Alotaibi, Ohoud S. Almalki, Adnan Alharbi, and Mohammad S. Alzahrani. "Medication Non-Adherence among Patients with Chronic Diseases in Makkah Region." Pharmaceutics 14, no. 10 (September 22, 2022): 2010. http://dx.doi.org/10.3390/pharmaceutics14102010.

Повний текст джерела

Анотація:

Background: The Makkah region is the most populated region in Saudi Arabia. Studying medication adherence levels may help to improve general health outcomes and decrease overall health care expenditures. Methods: We used the ARMS scale to assess medication adherence. Bivariable analysis of medication non-adherence was performed. Simple and multiple logistic regression models were built to identify factors associated with medication non-adherence. Results: Participants from the Makkah region were more than two times more likely to be non-adherent to their medications compared to other regions (adjusted OR = 2.58, 95% CI: 1.49–4.46). Patients who dispensed their prescriptions at their own expense were two times more likely to be non-adherents (adjusted OR = 2.36, 95% CI: 1.11–4.98). Patients who had a monthly income ≤6000 SR were almost two times more likely to be non-adherents (unadjusted OR = 1.73, 95% CI: 1.05–2.84). Conclusion: Medication adherence is one of the most important factors to help managing the disease. We found that Makkah chronic patients are more likely to be non-adherent with their medications compared to other regions’ patients. Moreover, we found that lower monthly incomes and paying for medications out-of-pocket were significant predictors of medication non-adherence.

Стилі APA, Harvard, Vancouver, ISO та ін.

Volpi, Simiane Salete, Daiana Biduski, Ericles Andrei Bellei, Danieli Tefili, Lynn McCleary, Ana Luisa Sant’Anna Alves, and Ana Carolina Bertoletti De Marchi. "Using a mobile health app to improve patients’ adherence to hypertension treatment: a non-randomized clinical trial." PeerJ 9 (May 28, 2021): e11491. http://dx.doi.org/10.7717/peerj.11491.

Повний текст джерела

Анотація:

Poor adherence to hypertension treatment increases complications of the disease and is characterized by a lack of awareness and acceptance of ongoing treatment. Mobile health (mHealth) apps can optimize processes and facilitate access to health information by combining treatment methods with attractive solutions. In this study, we aimed at verifying the influence of using an mHealth app on patients’ adherence to hypertension treatment, also examining how user experience toward the app influenced the outcomes. A total of 49 participants completed the study, men and women, diagnosed with hypertension and ongoing medical treatment. For 12 weeks, the control group continued with conventional monitoring, while the experimental group used an mHealth app. From the experimental group, at baseline, 8% were non-adherent, 64% were partial adherents and 28% were adherent to the treatment. Baseline in the control group indicated 4.2% non-adherents, 58.3% partial adherents, and 37.5% adherents. After follow-up, the experimental group had an increase to 92% adherent, 8% partially adherent, and 0% non-adherent (P < 0.001). In the control group, adherence after follow-up remained virtually the same (P ≥ 0.999). Results of user experience were substantially positive and indicate that the participants in the experimental group had a satisfactory perception of the app. In conclusion, this study suggests that using an mHealth app can empower patients to manage their own health and increase adherence to hypertension treatment, especially when the app provides a positive user experience.

Стилі APA, Harvard, Vancouver, ISO та ін.

Martsevich, S. Yu, Yu V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, et al. "Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)." Rational Pharmacotherapy in Cardiology 14, no. 6 (January 5, 2019): 891–900. http://dx.doi.org/10.20996/1819-6446-2018-14-6-891-900.

Повний текст джерела

Анотація:

Aim. To study adherence to treatment with generic statins prescribed to patients with high and very high cardiovascular risk in routine clinical practice, as well as the possible impact of educational training of doctors on compliance with clinical guidelines and changes in patient adherence to treatment. Material and methods. The study was prospective, with educational training for physicians on the main provisions of current clinical guidelines prior to the program. It included 3 visits over 12 weeks: inclusion visit (V0), and visits after 1 and 3 months of follow-up (V1 and V3). The use of generic atorvastatin or rosuvastatin was recommended for all patients. To assess adherence the following surveys were used: medical survey (all visits), the original questionnaire to assess the potential and the actual commitment to taking statins and the causes of non-adherence, and the Morisky-Green 8-question test (visits V0 and V3) to evaluate overall adherence to drug treatment. The patients who started the drug taking according to the medical recommendations and continued it during the study were considered as adherents. Patients who started but stopped taking the drug for 12 weeks were considered as partially non-adherent. Patients who refused to take the recommended statin were considered as non-adherents. The prescribed doses of statins and medical tactics in the titration of doses, as well as the achievement of the target level of low-density lipoprotein cholesterol (LDL cholesterol) were evaluated. Results. 112 (37.5%) of the 298 patients with baseline indications for taking statins did not take these drugs. According to the medical survey at V0 a total of 286 (96%) patients were potential adherents to medical recommendations; at V3 262 (88%) patients were adherent to statin treatment; 34 patients were partially non-adherent, 1 – was non-adherent, and 1 – dropped out of the study immediately after V0. According to the original questionnaire, potential adherence was assessed in 281 patients: 244 (86.8%) were potentially adherent, 37 (13.2%) – partially non-adherent. At V3, out of 294 patients who filled in the original questionnaire, 260 (88.5%) were adherent, 26 (8.8%) – partly non-adherent, 8 (2.7%) – nonadherent. The Morisky-Green questionnaire was filled in by 292 patients: at V0, 106 patients (36.3%) had treatment adherence, non-adherence – 186 patients (63.7%). By V3, an increase in total adherence was found: 159 patients (54.5%) were adherent, and 133 (45.5%) – non-adherent. The lipid profile was evaluated in 231 patients in V1 and in 285 ones – in V3. The target LDL cholesterol level was reached by V1 in 47 (20.3%) patients, and in 184 (79.7%) patients – was not. Dose titration occurred in 56 patients. By V3, 121 (42.4%) patients reached the target level of LDL cholesterol, and 164 – did not. The results of the lipid profile analysis were erroneously interpreted in 21 patients. Conclusion The results of the medical survey and the original questionnaire for assessing adherence predominantly coincided. The Morisky-Green test does not accurately reflect patients' commitment to taking a particular drug. Clinical inertness of doctors in the titration of statin doses and achievement of target LDL cholesterol levels were found as well as erroneous interpretation of the LDL cholesterol level. Educational trainings for doctors had a positive effect on the implementation of clinical guidelines, and also contributed to increasing patient adherence to medical recommendations.

Стилі APA, Harvard, Vancouver, ISO та ін.

Prunerová, Anna, Tereza Nováková, Karel Kupka, and Petra Reckziegelová. "Patients’ adherence to physiotherapy." Rehabilitace a fyzikální lékařství 28, no. 2 (July 16, 2021): 89–95. http://dx.doi.org/10.48095/ccrhfl202189.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Park, Yongwhi, Yong-Hwan Park, and Ki-Soo Park. "Determinants of Non-Adherences to Long-Term Medical Therapy after Myocardial Infarction: A Cross-Sectional Study." International Journal of Environmental Research and Public Health 17, no. 10 (May 20, 2020): 3585. http://dx.doi.org/10.3390/ijerph17103585.

Повний текст джерела

Анотація:

Purpose: Non-adherence to medications can be classified as unintentional and intentional. The aim of this study was to establish the major determinants of each non-adherence in myocardial infarction (MI). We also evaluated the effects of non-adherences on healthy behaviors. Materials and Methods: We enrolled 510 patients >1 year after MI. Nonadherences classified as unintentional or intentional were measured by a self-reported questionnaire. Polynomial and multiple regression analysis were performed to evaluate the determinant of each type of nonadherences. Results: Among patients with nonadherence, 263 (70.7%) patients were unintentionally non-adherent while 109 (29.3%) patients were intentionally non-adherent. Psychological belief and attitude were important in unintentional non-adherence (Exp(β) = 0.917, p = 0.050 for anxiety; Exp(β) = 1.191, p = 0.001 for concerns). Beliefs about medications were the strongest determinant of intentional non-adherence (Exp(β) = 0.812, p < 0.001 for necessity; Exp(β) = 1.421, p < 0.001 for concerns). Anxiety was important determinant of intentional non-adherence (Exp(β) = 0.889, p = 0.015). Conclusion: Psychological factors and beliefs about medication were important determinants of both types of non-adherence. Combined approaches targeting the beliefs about medications and psychological distress are needed to improve drug adherence in patients with MI.

Стилі APA, Harvard, Vancouver, ISO та ін.

Kumar, Manan Abhay, Sahana S, and Soumya K. N. C. R. Manjunath. "Medication Adherence of TB Patients using IoT." International Journal of Trend in Scientific Research and Development Volume-2, Issue-4 (June 30, 2018): 677–83. http://dx.doi.org/10.31142/ijtsrd13049.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Mohammad Javad Hashemi, Mohammad Manaf, Bhanu Priya HR, Laween Merris Lenos, Prabhu M, and Ragunatha S. "A descriptive study of factors associated with anti-fungal medication adherence among patients with dermatophytosis." International Journal of Research in Pharmaceutical Sciences 11, no. 4 (December 20, 2020): 7027–33. http://dx.doi.org/10.26452/ijrps.v11i4.3806.

Повний текст джерела

Анотація:

The prevalence of superficial Mycotic infection worldwide is 20–25%. Medication non-adherence in patients leads to worsening of the disease, death and increased health care costs. More than 30% of medicine-related hospital admissions occur due to medication non-adherence. The aim of the study is assessing the factors associated with medication adherence in patients with dermatophytosis. Data were analyzed by using descriptive analysis of 305 patients attending the dermatology department. The period of study was three months. Medication adherence was determined using Morisky Green Levine Scale for dermatophytosis patients who are undergoing treatment. KAP (knowledge, attitude, practice) was used to determine the knowledge gaps, general health practice, and beliefs of the patient towards fungal infection. It was found that 47.86% of the subjects in the study are non- adherent and 49.50% are moderate adherents, and only 2.62% are highly adherent to medications prescribed. In KAP study, it was found that (14.4%) strongly agree that fungal infection does not create hindrance in normal life, while (28.85%) strongly disagree. Practice where analyzed in 305 subjects, (52.13%) share clothing with family members or friends, (50.16%) do not take medication as prescribed. The patient affected with fungal infections had poor adherence to the medicines prescribed. The risk factors affecting medication adherence are poor hygiene, sharing of cloths of friends or family, dosing schedule, complex regimens, access barriers, and cost of the drug. Patient education, in the early stages of fungal infection, can avoid non- adherence.

Стилі APA, Harvard, Vancouver, ISO та ін.

Rabba, Abdullah K., Waleed S. Aljiris, Nehad J. Ahmed, and Khalid M. Alkharfy. "MEDICATION ADHERENCE ‎IN TYPE 2 DIABETIC PATIENTS: A STUDY IN SAUDI ARABIA‎." International Journal of Pharmacy and Pharmaceutical Sciences 9, no. 10 (November 1, 2017): 247. http://dx.doi.org/10.22159/ijpps.2017v9i11.16963.

Повний текст джерела

Анотація:

Objective: To assess the extent of antidiabetic drug adherence in patients with type 2 diabetes mellitus, and different factors affecting adherence in outpatient clinics in Alkharj city, Kingdom of Saudi Arabia. Methodology: Type 2 diabetic patients attending two outpatient clinics in Alkharj city, KSA, were randomly selected, and interviewed for information regarding their antidiabetic drug adherence. A six-item questionnaire was used to measure the level of adherence in study participants. Participants scoring six points are categorized as (high adherent), while scores of 4 to 5 puts the participants in the (medium adherence) category, and participants with scores less than 4 are of (Low adherence). Patient’s records were also, reviewed, for relevant lab and clinical data.Results: 68 type 2 diabetic patients participated in this study from April 2014 to September 2014. Majority of participants (73.5%) were of 40 to 60 years old. Hypertension and/or lipid disorders were encountered in majority of patients in this study. 26.5% of patients in this study were categorized as (high adherent), 55.9% as (medium adherent), and 17.6% as (low adherent). 72% of patients had an HbA1c level of ≥7% suggesting poor control of their disease. Patients with a longer history of diabetes, and patients with HbA1c level less than 7% found to achieve better adherence levels (p-value<0.05). Conclusion: Subjective information from patients suggested accepted level of adherence. Nevertheless, objective measurements of HbA1c, suggest poor glycemic control that possibly reflect poor adherence to antidiabetic medications.

Стилі APA, Harvard, Vancouver, ISO та ін.

Mukherjee, Dibyendu, Suman Naiya, Suvajit Chakraborty, Rahul D. Chakrabarty, and Sucharita Patra. "Adherence to methotrexate therapy among rheumatoid arthritis patients in Eastern India." International Journal of Advances in Medicine 7, no. 6 (May 22, 2020): 899. http://dx.doi.org/10.18203/2349-3933.ijam20202066.

Повний текст джерела

Анотація:

Background: This study aims to identify adherence rate of methotrexate (MTX) therapy in rheumatoid arthritis (RA) patients of Eastern India and recognize factors contributing to treatment adherence in those patients.Methods: In this cross-sectional observational study, a total of 140 patients (17 males, 123 females; mean age 37.6±7.4 years) with pre-diagnosed RA attending the rheumatology outpatients clinic between February 2019 and January 2020 fulfilling the inclusion and exclusion criteria, were included. The patients were evaluated in terms of sociodemographic factors, clinical and medication details, disease activity score (DAS28-CRP) values and patient - doctor considerations that might contribute to treatment adherence. They filled out a series of standardised present questionnaires including the Morisky 8-item Medication Adherence Scale (MMAS-8). Data was analysed statistically and compounded.Results: Of the patients, 29 (20.7%) were adherent and 111 (79.3%) were non-adherent to medication with MTX. 65% were on MTX monotherapy and 35% on polytherapy with csDMARDs. 45.7% of the non-adherent forgot taking medication, 50.7% skipped during travel, 79.3% intentionally did not comply with strict regimen. The DAS28-CRP scores were much higher amongst non-adherent group and fewer reached remission as compared to adherent participants. Commonest reason for non-adherence being adverse drug reaction and financial constraints. Conclusions: This study showed a significantly higher adherence to MTX treatment compared to most previous studies. Adverse drug reactions, financial constraints, complex treatment regimen, long treatment duration, and frequent travel history significantly affect medication adherence in this patient population. Higher the adherence better the treatment response.

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Patients adherence"

Aljabaa, Aljazi Hussain. "Adherence among orthodontic patients." Thesis, King's College London (University of London), 2016. https://kclpure.kcl.ac.uk/portal/en/theses/adherence-among-orthodontic-patients(3184705a-7a98-4381-a0fa-9f5d61734f54).html.

Повний текст джерела

Анотація:

Objectives: A patient’s adherence is an important factor for successful orthodontic treatment. This adherence can take the form of maintaining good oral hygiene, appliance maintenance, observing dietary recommendations, and appointment keeping. This thesis consisted of three studies. A systematic review was conducted to investigate the effectiveness of interventions to enhance adherence among orthodontic patients aged 12 to 18. Specific adherence outcomes included: recall of information given by the orthodontic team; attendance at orthodontic appointments; self-reported oral hygiene behaviour; and clinical indices of oral hygiene. A survey was undertaken to explore predictors of adherence amongst patients 12–18 years of age receiving orthodontic treatment with fixed appliances at the initial follow-up appointment 6 weeks post bracket placement. Finally, a randomised controlled trial compared three methods designed to enhance adherence to oral hygiene instructions in orthodontic patients aged 12–18 years: mind map, if-then plan, and leaflet. Materials and Methods: Systematic review: Electronic searches of Medline via OVID (1966– March 2012), EMBASE, and the Cochrane central register of control trials from its inception to March 2012, as well as a hand search were undertaken to identify relevant studies. The longitudinal study: Measured adherence to orthodontic treatment in terms of self-reported oral hygiene-related behaviour, oral hygiene maintenance, knowledge of oral health-related behaviour, appliance breakages, and appointment attendance among 200 individuals undergoing maxillary and mandibular fixed orthodontic appliances with an age range of 12 to 18 years. Oral health-related behaviour and clinical indicators of oral healthwere assessed at bond-up appointment (T1) and at 6 weeks follow up appointment (T2) to determine their relationship to adherence. Randomised controlled trial: Orthodontic patients from Guy’s and St Thomas’ NHS Trust were drawn as potential participants; patients were randomly allocated to one of the three interventions used. Eligibility criteria: patients aged 12–18 years undergoing maxillary and mandibular fixed orthodontic treatment. Individuals with systemic disease, craniofacial development disorders including cleft lip and palate, individuals with previous history of orthodontic treatment, patients attending the specialist hypodontia clinic and individuals who declined to participate were excluded. Outcomes: Primary outcomes: plaque levels. Secondary outcomes: bleeding on probing, patient’s knowledge about adherence in orthodontic treatment, and self-reported behaviours. Randomisation: patients were randomly allocated to one of three conditions. The three groups were: mind mapping, if-then planning group, and patient information tools (leaflet). Allocation was concealed using sealed envelopes. Blinding: the participant and their parents as well as the researcher undertaking the intervention and assessing the outcomes were not blinded. The statistician undertaking the statistical analysis was blinded. Participants were assessed at four time points: at the fitting of the fixed appliance (T1); at initial follow-up 6 weeks later, at which time after the assessment of their oral hygiene and completion of the questionnaire (T2), they were randomly allocated to the three groups of intervention; 6 weeks after the intervention (T3); and 18 weeks after the intervention (T4).Results: Systematic Review: A total of 381 articles were identified through the electronic searches. Initial screening of the abstracts and titles by all review authors identified 7 articles that met the inclusion criteria for this review. The full articles were then retrieved. Four randomised controlled trials were found; all used different methods of intervention, including: a system of rewards or awards; the Hawthorne effect; written information; and demonstration of the microbiology of plaque. The longitudinal study: Significant changes in lingual plaque (P= 0.026), bleeding on probing (P= 0.006), and knowledge (P < 0.001) were found between bond-up and at initial follow-up. There were no relationships between age and gender of the patients and adherence. Clinical status at bond-up was the only significant predictor of clinical status at initial follow-up. Randomised Controlled Trial: Total sample of 90 participants were randomised in a 1:1:1 ratio. No statistical differences were found in adherence among the three methods used. Conclusion: The literature advocates the use of several methods to improve compliance/adherence among orthodontic patients. While there is insufficient evidence to allow clinicians to choose a single method, the results demonstrate the value of spending time with patients to illustrate the importance of adherence. Future studies should develop multiple methods of assessing patient adherence including self-report, behavioural observation and recording, as well as change in clinical indices, with different types of interventions to be included and tested for effectiveness. The survey demonstrated that the oral hygiene of patients worsens following the start of orthodontic treatment. Age, gender, and knowledge are not good predictors of adherence. However, initial clinical status predicts subsequent adherence. The randomised controlled trial revealed no differences in adherence among the three methods used.

Стилі APA, Harvard, Vancouver, ISO та ін.

Joice, Sara A. "Adherence in behavioural interventions for stroke patients : measurement and prediction." Thesis, University of St Andrews, 2005. http://hdl.handle.net/10023/7262.

Повний текст джерела

Анотація:

Background: With the increasing incidence in stroke and the resultant high prevalence of residual disability resources are not adequately meeting the needs of the patients. Furthermore patients continue to express dissatisfaction with their care. New interventions are being developed and evaluated. However, when offered these new interventions, patients may refuse or not participate fully. A stroke workbook intervention was developed through a line of research examining the role of perceived control in recovery. During the randomised controlled trial (RCT) evaluating its efficacy patients failed to fully participate in the activities proposed in the workbook. Why, when there is such a dearth of treatment available, do stroke patients not fully participate in or adhere to the interventions offered? Methods: Three studies were conducted, a predictive study using the intervention group of the RCT exploring the demographic, clinical and psychological factors predicting adherence; a predictive study using one of the intervention groups from a larger 2x2 RCT to examine the predictors of adherence to an easier intervention (video); and a third longitudinal study examining the efficacy of an even simpler intervention (letter) on increasing adherence to the video. The theoretical framework of Leventhal's Self Regulation Model was used to develop the letter intervention and to explain the findings. Results: Five types of adherence behaviours emerged from the three studies, all with their own difficulties of definition, measurement and their individual predictor variables. Gender, impairment and illness representations were all predictive of adherence. An easier intervention promoted adherence especially for men and the more impaired. Women appeared to adhere more readily to the complex intervention. These gender differences may be associated with illness representations. A theoretical-based letter does not increase adherence per se but may increase the amount of adherence to an easier intervention. Conclusion: Adherence behaviour is not one type of behaviour and is associated with measurement difficulties. The Self-Regulation model appeared to offer some logical explanations to the findings. The findings have clinical implications and could possibly be associated with patients' satisfaction with care.

Стилі APA, Harvard, Vancouver, ISO та ін.

Gamble, Jacqueline Margaret. "Medication adherence in patients with difficult asthma." Thesis, Queen's University Belfast, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.527931.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Thomas, Valarie Finley. "Increasing Patients' Understanding of Prescribed Medication Adherence." ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/5422.

Повний текст джерела

Анотація:

The cost of healthcare in the United States has increased due to growing numbers of patients who live with chronic health problems, such as heart disease. The cost of healthcare is compounded by the cost in terms of complications of cardiovascular disease secondary to medication non-adherence. Education about medication use and adherence, safety, and side effects was needed for patients in a cardiovascular unit to improve adherence to medications as prescribed. Results of a health care provider (HCP) and nursing staff needs assessment provided by the site showed the need for improved cardiovascular medication education. The project focused question asked if cardiovascular patient medication education provided to HCPs and nursing staff would be incorporated into practice by the HCPs and nursing staff. The purpose of the project was to improve the education provided to patients by the HCPs and nursing staff. A literature review provided content for the educational program. Strategies to promote adherence and medication safety and a patient education worksheet were presented with guidance on implementation. Post education qualitative results from HCPs and nursing staff showed that the sheet was implemented and helpful with educating cardiovascular patients. This project promotes positive social change by the implementation of a patient education program that may improve patient education and adherence to cardiovascular medications. As a result, improved adherence to medications may reduce patient and healthcare related costs long term.

Стилі APA, Harvard, Vancouver, ISO та ін.

Khatib, R. "Adherence to secondary prevention medicines by coronary heart disease patients : first reported adherence." Thesis, University of Bradford, 2012. http://hdl.handle.net/10454/5484.

Повний текст джерела

Анотація:

Background Non-adherence to evidence based secondary prevention medicines (SPM) by coronary heart disease (CHD) patients limits their expected benefits and may result in a lack of improvement or significant deterioration in health. This study explored self-reported non-adherence to SPM, barriers to adherence, and the perception that patients in West Yorkshire have about their medicines in order to inform practice and improve adherence. Methods In this cross-sectional study a specially designed postal survey (The Heart Medicines Survey) assessed medicines-taking behaviour using the Morisky Medicines Adherence 8 items Scale (MMAS-8), a modified version of the Single Question Scale (SQ), the Adherence Estimator (AE), Beliefs about Medicines Questionnaire(BMQ) and additional questions to explore practical barriers to adherence. Patients were also asked to make any additional comments about their medicines-taking experience. A purposive sample of 696 patients with long established CHD and who were on SPM for at least 3 months was surveyed. Ethical approval was granted by the local ethics committee. Results 503 (72%) patients participated in the survey. 52%, 34% and 11% of patients were prescribed at least four, three and two SPMs respectively. The level of non-adherence to collective SPM was 44%. The AE predicted that 39% of those had an element of intentional non-adherence. The contribution of aspirin, statins, clopidogrel, beta blockers, angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) to overall non-adherence as identified by the SQ scale was 62%, 67%, 7%, 30%, 22% and 5%, respectively. A logistic regression model for overall non-adherence revealed that older age and female gender were associated with less non-adherence (OR = 0.96, 95% CI: 0.94, 0.98; OR = 0.56, 95% CI: 0.34, 0.93; respectively). Specific concern about SPM, having issues with repeat prescriptions and aspirin were associated with more non-adherence (OR = 1.12, 95% CI: 1.07, 1.18; OR = 2.48, 95% CI: 1.26, 4.90, OR = 2.22, 95% CI: 1.18, 4.17). Other variables were associated with intentional and non-intentional non-adherence. 221 (44%) patients elaborated on their medicines-taking behaviour by providing additional comments about the need for patient tailored information and better structured medicines reviews. Conclusions The Medicines Heart Survey was successful in revealing the prevalence of self-reported non-adherence and barriers to adherence in our population. Healthcare professionals should examine specific modifiable barriers to adherence in their population before developing interventions to improve adherence. Conducting frequent structured medicines-reviews, which explore and address patients' concerns about their medicines and healthcare services, and enable them to make suggestions, will better inform practice and may improve adherence.

Стилі APA, Harvard, Vancouver, ISO та ін.

Williams, Amanda L. "Physician adherence to communication tasks with adult vs. older adult female patients." CardinalScholar 1.0, 2010. http://liblink.bsu.edu/uhtbin/catkey/1560844.

Повний текст джерела

Анотація:

The study investigated whether physician communication adherence was similar between adult and older adult female patients in a family medicine setting. Additionally, the study investigated whether or not the level of communication adherence was related to patient perceptions of working alliance. Previous research has failed to adequately examine age as a variable in physician-patient communication and has neglected to examine the working alliance within the physician-patient relationship. The sample included 41 adult female, family medicine patients, who agreed to have their appointment with their physician videotaped. The videotaped encounters were coded by trained observers using the Behavioral Science Tape Review Checklist (BSTRC). Participants also completed the Working Alliance Inventory-Short Form (WAI-SF). Results from the study suggested that physician adherence to communication tasks did not vary significantly between adult patients and older adult patients. Further, results demonstrated that the combination of responses to the bond and tasks subscales of the WAI-SF significantly accounted for 16% of the variance in communication adherence.
Department of Counseling Psychology and Guidance Services

Стилі APA, Harvard, Vancouver, ISO та ін.

Cerimagic, Zlata. "Self-reported medication adherence among patients with diabetes /." View online ; access limited to URI, 2004. http://0-wwwlib.umi.com.helin.uri.edu/dissertations/dlnow/3145414.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Dos, Reis Juliao. "Factors associated with medication adherence among tuberculosis patients in Timor-Leste." Thesis, Queensland University of Technology, 2016. https://eprints.qut.edu.au/94662/1/Juliao_Dos%20Reis_Thesis.pdf.

Повний текст джерела

Анотація:

This thesis investigated medication adherence among people living with tuberculosis in Timor Leste. Suboptimal adherence was commonly reported, and was influenced by service inaccessibility, family poverty, patients' absence of disease symptoms and misperception of recovery, untreated depression and a popular cultural belief that luck or chance determines health outcomes. The study has implications for improving health literacy and counselling programs to achieve effective adherence to medication and good health outcomes.

Стилі APA, Harvard, Vancouver, ISO та ін.

Michel, Marielena. "Health literacy and treatment adherence among Latinos with end stage renal disease." CSUSB ScholarWorks, 2008. https://scholarworks.lib.csusb.edu/etd-project/3359.

Повний текст джерела

Анотація:

The purpose of this study was to examine health literacy and treatment adherence among Latinos with end stage renal disease. Health literacy has been overlooked as one of the factors that affects one's ability to comply with the physician's prescribed medical treatment.

Стилі APA, Harvard, Vancouver, ISO та ін.

Krolop, Linda [Verfasser]. "Adherence Management for Cancer Patients on Capecitabine / Linda Krolop." Bonn : Universitäts- und Landesbibliothek Bonn, 2013. http://d-nb.info/1046622641/34.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Книги з теми "Patients adherence"

F, George Charles, and Royal Society of Medicine (Great Britain), eds. Adherence with medication in congestive heart failure. London: Royal Society of Medicine Press, 1997.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Improving medication adherence: How to talk with patients about their medications. Philadelphia, Pa: Wolters Kluwer Health, 2006.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Sarna, Avina. Examining adherence and sexual behavior among patients on antiretroviral therapy in India. New Delhi: Population Council, 2006.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Dennis, Drotar, ed. Promoting adherence to medical treatment in chronic childhood illness: Concepts, methods, and interventions. Mahwah, NJ: L. Erlbaum Associates, 2000.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

United States. Health Resources and Services Administration, ed. HIV/AIDS health care utilization & medical adherence issues among HIV seropositive African women in Miami. [Rockville, Md.?]: U.S. Dept. of Health & Human Services, Public Health Service, Health Resources and Services Administration, 1995.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Chirwa, Patrick W. Exploring the psychosocial factors that lead to poor ART adherence among HIV positive clients in Rumphi District Hospital and Bolero Rural Hospital. Mzuzu [Malawi]: Mzuni Press, 2018.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

United States. Health Resources and Services Administration., ed. HIV/AIDS health care utilization & medical adherence issues among HIV seropositive African American women in Miami. [Rockville, Md.?]: U.S. Dept. of Health & Human Services, Public Health Service, Health Resources and Services Administration, 1995.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bosworth, Hayden, ed. Improving Patient Treatment Adherence. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-5866-2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

C, Turk Dennis, ed. Facilitating treatment adherence. New York: Plenum, 1987.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Advance treatment directives and autonomy for incompetent patients: An international comparative survey of law and practice, with special attention to the Netherlands. Lewiston: Edwin Mellen Press, 2008.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Частини книг з теми "Patients adherence"

Cline, Abigail, Adrian Pona, and Steven R. Feldman. "Adherence in Patients with Comorbidities." In Treatment Adherence in Dermatology, 51–58. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-27809-0_6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Davis, Scott A., and Steven R. Feldman. "How Providers Can Assess Their Patients’ Adherence in Clinical Settings." In Adherence in Dermatology, 61–68. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-30994-1_7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Schwartz, David D., and Marni E. Axelrad. "Screening for Nonadherence in Pediatric Patients." In Healthcare Partnerships for Pediatric Adherence, 151–61. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13668-4_12.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Brown, Scott C. "How Older Patients Learn Medical Information." In Medical adherence and aging: Social and cognitive perspectives., 93–121. Washington: American Psychological Association, 2007. http://dx.doi.org/10.1037/11557-005.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Gianfranco, Parati, Pellegrini Dario, and Torlasco Camilla. "Use of Apps to Improve Drug Adherence in Hypertensive Patients." In Drug Adherence in Hypertension and Cardiovascular Protection, 283–93. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-76593-8_21.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Sobieski, Danielle, and Georgiana Mitrus. "Current Dietary Advances in Enhancing Adherence in ESRD Patients." In Technological Advances in Care of Patients with Kidney Diseases, 71–81. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-11942-2_6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Lampert, Steven Michael, Alan David Kaye, Richard D. Urman, and Laxmaiah Manchikanti. "Drug Testing and Adherence Monitoring in Substance Abuse Patients." In Substance Abuse, 621–31. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-1951-2_45.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

McLaughlin, Anne Collins, Wendy A. Rogers, and Arthur D. Fisk. "Helping Patients Follow Their Doctor's Instructions: Matching Instructional Media to Task Demands." In Medical adherence and aging: Social and cognitive perspectives., 251–67. Washington: American Psychological Association, 2007. http://dx.doi.org/10.1037/11557-011.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Kinnaert, P., N. Van Geertruyden, B. Bournonville, J. Bastenier, and J. L. Leclerc. "Granulocyte Adherence in Patients Undergoing Cardiac Surgery Under Cardiopulmonary Bypass." In Immune Consequences of Trauma, Shock, and Sepsis, 247–49. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-73468-7_31.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Santoso, Setiyo Budi, Nurkholis Ashari, and Ika Mulyono Putri Wibowo. "Is the Therapeutic Adherence of Hypertensive Patients Closely Related to the Pharmacist-Patient Communication?" In Proceedings of the 3rd Borobudur International Symposium on Humanities and Social Science 2021 (BIS-HSS 2021), 34–39. Paris: Atlantis Press SARL, 2023. http://dx.doi.org/10.2991/978-2-494069-49-7_7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Patients adherence"

Saad, Rahma, Mohammed Al- Hashemi, Theodoros Papasavvas, and Karam Turk-Adawi. "Patient Factors associated with Adherence and Change in Cardiac Risk Factors among Cardiac Rehabilitation Patients in Qatar." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0159.

Повний текст джерела

Анотація:

Background: Cardiovascular disease is the number one killer in Qatar (1). Cardiac rehabilitation (CR) is a secondary prevention model of care for cardiac patients. It is proven that CR reduces cardiovascular mortality by 20% (2). However, CR is underutilized worldwide, with low enrolment and adherence rates (3). This study aims (a) to investigate factors associated with adherence (median number of sessions, i.e. 21), and (b) to examine the relationship between adherence and change in cardiac risk factors, i.e. blood pressure, cholesterol, and low-density lipoprotein (LDL). Method: This retrospective cohort study included 714 cardiac patients, aged ≥18 years, who were referred to the cardiac rehabilitation program in Qatar. Data were collected from patients records from January 2013-September 2018. Logistic regression models were used to assess factors associated with adherence. Multiple linear regression models were used to examine the relationship between number of CR sessions attended and changes in cardiac risk factors. Results: The mean age of the study population was 52.7±10.1 years (mean ± SD). The majority of patients were males (n=641, 89.8%) and non-Qatari (n= 596, 83.5%),i.e. similar to Qatar population profile of 75% males and 15% Qatari, one fourth were smokers (n=185, 25.91%), and one fifth (n=128, 18.8%) had severe depression. Patients with AACVPR moderate- and high-risk levels were more likely to adhere compared to those with low risk. Percutaneous intervention and musculoskeletal disease were negatively associated with adherence. We found clinically significant improvements among adherents compared to non-adherents; reduction of 10% in cholesterol, and 15% in low density lipo-protein. Conclusion: This study provides new insights in Qatar, setting into factors that lead patients to adhere to their CR sessions. These factors represent opportunities for targeted interventions to improve CR utilization.

Стилі APA, Harvard, Vancouver, ISO та ін.

Nieuwenhuis, H. K., J. J. Zwaginga, and J. J. Sixma. "ANALYSIS OF PATIENTS WITH A PROLONGED BLEEDING TIME." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644750.

Повний текст джерела

Анотація:

The bleeding time (BT) is one of the most important screening tests in patients with a bleeding tendency. Investigations of Von Willebrand Factor and aggregation tests form routine diagnostic tools to analyse a prolonged BT. In many patients, however, this approach fails to explain the bleeding tendency because no abnormality is found. In order to deal with this problem , we chose three methods: I) determination of platelet nucleotides and serotonin in all patients with a prolonged BT, independent of the results of aggregation tests, II) measurement of platelet adherence to purified collagen and the matrix of endothelial cells in a perfusion system, III) measurement of adherence of normal blood to matrix of patients' fibroblasts. I) In a group of 145 patients with a prolonged BT and a normal platelet count the diagnosis von Willebrand1's disease was made in 52 patients (36%), congenital Storage Pool Disease (SPD) in 27 pts (18%), defect of thromboxane synthesis in 4 pts (3%) and platelet function disorders with miscellaneous aggregation abnormalities in 23 pts (16%). No abnormalities were found in 39 pts (27%). Analysis of aggregation tests, disclosed normal aggregation tracings in many patients with SPD: 23% of 106 patients with congenital or acquired SPD had normal aggregation tests.Adhesion studies were performed with the blood of 7 patients with an unexplained prolonged bleeding time. Two patients had a severe defect and one patient a mild defect of adherence. Further studies revealed the presence of an autoantibody on the platelets in one of these patients.In order to diagnose vessel wall defects which may cause a prolonged BT, we studied the adherence of normal blood to the matrix of the fibroblasts of one patient. We found a decreased adherence, which suggests the presence of a vessel wall defect causing a prolonged BT.We conclude that in many patients with a prolonged BT and normal VWF parameters and normal aggregation tests, SPD or adhesion defects may be responsible for a bleeding tendency.

Стилі APA, Harvard, Vancouver, ISO та ін.

Boutrup, Jeppe, Kenni Odelheim, Naveen Bagalkot, and Tomas Sokoler. "MyReDiary: Exploring the design for supporting adherence to physical rehabilitation." In ICTs for improving Patients Rehabilitation Research Techniques. IEEE, 2013. http://dx.doi.org/10.4108/icst.pervasivehealth.2013.252067.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Rocha, José Claudio Casali da. "THE INFLUENCES OF ADHERENCE TO TAMOXIFEN AND CYP2D6 PHARMACOGENETICS ON PLASMA CONCENTRATIONS OF THE ACTIVE METABOLITE (Z)-ENDOXIFEN IN BREAST CANCER." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2025.

Повний текст джерела

Анотація:

Tamoxifen efficacy in breast cancer is suspected to depend on adherence and intact drug metabolism. We evaluated the role of adherence behavior and pharmacogenetics on the formation rate of (Z)-endoxifen. In 192 Brazilian patients, we assessed plasma levels of tamoxifen and its metabolites at 3, 6, and 12 months of treatment (LC-MS/MS), adherence behavior (Morisky Medication Adherence Scale), and CYP2D6 and other pharmacogene polymorphisms (MALDI-TOF mass spectrometry and real-time PCR). Adherence explained 47% of the variability of tamoxifen plasma concentrations (p<0.001). While CYP2D6 alone explained 26.4%, the combination with adherence explained 40% of (Z)-endoxifen variability at 12 months (p<0.001). The influence of low adherence not to achieving relevant (Z)-endoxifen levels was the highest in patients with non-compromised CYP2D6 function (RR 3.65, 95%CI 1.48–8.99). As a proof-of-concept, we demonstrated that (Z)-endoxifen levels are influenced by patient adherence to both tamoxifen and CYP2D6, which is particularly relevant for patients with full CYP2D6 function.

Стилі APA, Harvard, Vancouver, ISO та ін.

Varshney, U., and R. Vetter. "Medication adherence for patients with mental illness." In 2012 34th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2012. http://dx.doi.org/10.1109/embc.2012.6346394.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Mustafa, Fadhil Ilham, Nurfitri Bustamam, and Andri Pramesyanti. "Association between Compliance Level on Fixed-Dose Combination Antiretroviral Drug and CD4 Level among HIV Patients." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.02.03.

Повний текст джерела

Анотація:

Background: People living with HIV / AIDS (PLWHA) have weak immune systems and are prone to infection. Therefore, PLWHA must take antiretroviral (ARV) to maintain their immunity. This study aimed to determine the relationship between the level of adherence to taking ARV fixed-dose combination (FDC) drugs and CD4 levels of HIV patients. Subjects and Method: This was a cross-sectional study conducted at Pengayoman Cipinang Hospital, Indonesia, in 2018. Total of 91 HIV patient over 17 years of age, had or had received FDC ARV therapy for at least 1 year, and did not experience drug-induced hepatitis were enrolled in this study. The dependent variable was CD4 level. The independent variable was level of adherence to taking ARV fixed-dose combination (FDC). The data were taken from the Voluntary Counseling and Testing Poli Pengayoman Cipinang Hospital. This study used secondary data from the Overview of HIV Care and ARV Therapy. The data were analyzed using Chi-square. Results: A total of 65.93% HIV patients had a good level of medication adherence and 79.12% had an increase of CD4 levels. There was a significant relationship between adherence to taking FDC ARV drugs and CD4 levels (OR = 6.50; 95% CI = 2.15 to 19.62; p<0.001), and it was statistically significant. Conclusion: There is a significant relationship between the level of adherence to taking FDC ARV drugs and CD4 levels. Therefore, patients must receive education and support to improve adherence to taking ARV drugs. Keywords: antiretroviral, CD4, fixed-dose combination, adherence to taking medication, people with HIV / AIDS Correspondence: Fadhil Ilham Mustafa. Faculty of Medicine, Universitas Pembangunan Nasional Veteran, Jakarta. Jl. RS Fatmawati, Pondok Labu, South Jakarta. Email: fadhilimn@gmail.com. Mobile: 081283681755. DOI: https://doi.org/10.26911/the7thicph.02.03

Стилі APA, Harvard, Vancouver, ISO та ін.

Gregoriano, Claudia, Simona Henny-Reinalter, Anja Handschin, Anna-Lisa Flamm, Thomas Dieterle, Isabelle Arnet, Kurt E. Hersberger, and Jörg D. Leuppi. "Patients' adherence to chronic treatment of pulmonary diseases." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa1061.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Badami, V., S. F. Z. Naqvi, J. Easterling, B. Hackett, M. Abdelfattah, R. C. Stansbury, and S. Sharma. "Positive Airways Pressure (PAP) Adherence in Hospitalized Patients." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4746.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Aghi, Manvi. "Digital intervention for Improving Medication Adherence among Patients." In India HCI 2021: India HCI 2021. New York, NY, USA: ACM, 2021. http://dx.doi.org/10.1145/3506469.3506487.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Lei, Jingxin, and Kent Lee. "Adherence of Upper Airway Stimulation in US and German Medical Centers: A Multicenter Meta-Analysis on Adhere Registry." In 2020 Design of Medical Devices Conference. American Society of Mechanical Engineers, 2020. http://dx.doi.org/10.1115/dmd2020-9026.

Повний текст джерела

Анотація:

Abstract Upper airway stimulation (UAS) is shown to be effective with high adherence for patients with moderate to severe obstructive sleep apnea. However, the consistency of adherence among medical sites remains to be verified. This study examines the adherence to UAS among medical sites in an international multicenter registry. A statistically significant adherence decrease between 6-month and 12-month visit was found in the study cohort as well as in most sites. No significant heterogeneity was found among sites with either all patients or only patients who had adherence at both visits recorded. In addition, there is no enough evidence that region and experience of sites influences the adherence. This study indicates that UAS therapy adherence is consistent among sites, regardless of region and experience of sites.

Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Patients adherence"

Rada, Gabriel. What are the effects of interventions to improve adherence to medication? SUPPORT, 2016. http://dx.doi.org/10.30846/1608084.

Повний текст джерела

Анотація:

The potential benefits of effective medications may not always be achieved if patients do not take them as prescribed. Adherence is defined as the extent to which a patient follows the instructions given for a prescribed treatment. Many adherence interventions are intended to assist patients with completing this task.

Стилі APA, Harvard, Vancouver, ISO та ін.

Mahmoudi, Farhad, Mahtab Mokarram, Sadegh Sabouhi, Sara Hashemi, Parastoo Saberi, and Hadi Zamanian. Application of digital health for improving medication adherence in MS patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0058.

Повний текст джерела

Анотація:

Review question / Objective: The aim of this study is to evaluate the efficacy of digital health interventions in monitoring and improving medication adherence in Multiple Sclerosis patients. Condition being studied: Multiple sclerosis (MS) is the most prevalent chronic inflammatory disease of the central nervous system (CNS), which leads to focal lesions in the white matter, characterized by selective primary demyelination with partial preservation of axons and reactive astrocytic gliosis. The disease is thought to be due to a complex interaction between different genetic and environmental factors. The prevalence of MS is rising all over the world, due on one hand to earlier diagnosis and prolonged survival, and on the other to a true increase in incidence of the disease. The diagnosis of MS remains clinical despite recent advances in diagnostics and relies on demonstrating dissemination in space and time while excluding alternative diagnoses.

Стилі APA, Harvard, Vancouver, ISO та ін.

Sarna, Avina, Indrani Gupta, Sanjay Pujari, A. K. Sengar, Rajiv Garg, and Ellen Weiss. Examining adherence and sexual behavior among patients on antiretroviral therapy in India. Population Council, 2006. http://dx.doi.org/10.31899/hiv2.1026.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Lewin, Simon, and Peter Steinmann. Do material incentives improve patient adherence in tuberculosis? SUPPORT, 2017. http://dx.doi.org/10.30846/1704152.

Повний текст джерела

Анотація:

Adherence to treatment for tuberculosis (TB) is frequently sub-optimal. However, good adherence is important for successful treatment and to minimize the risk of drug resistance. Adherence is also essential for different components of TB prophylaxis. Material incentives for patients to encourage them to take their treatment as prescribed, or to assist them in overcoming financial barriers to treatment, have been suggested as interventions to improve TB treatment adherence.

Стилі APA, Harvard, Vancouver, ISO та ін.

Bahns, Carolin, Bettina Scheffler, and Christian Kopkow. Guideline adherence in physiotherapy – protocol for a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0081.

Повний текст джерела

Анотація:

Review question / Objective: The objective of this systematic review is to summarise different approaches reported in studies to evaluate guideline adherence in physiotherapy care. Further, we aim to identify clinical and methodological factors that may explain the assumed heterogeneity of guideline adherence among physiotherapists. Condition being studied: Clinical practice guidelines are systematically developed statements that summarise the current state of knowledge from research and practice. They are intended to support clinicians and patients to make decisions about appropriate health care for specific clinical circumstances (2). Various studies show that evidence-based physiotherapy care can lead to improved patient outcomes (e.g. pain, function, quality of life) and at the same time contribute to a lower utilisation of medical services and a reduction in health care costs. The degree of agreement between medical or therapeutic care and the recommendations made in guidelines is often described in studies with the term "guideline adherence". However, the heterogeneous use of the term guideline adherence and the lack of a standardised research methods or operationalisation lead to limited comparability of the study results.

Стилі APA, Harvard, Vancouver, ISO та ін.

Rada, Gabriel. What are the effects of behavioral interventions to improve adherence to antiretroviral therapy? SUPPORT, 2017. http://dx.doi.org/10.30846/170206.

Повний текст джерела

Анотація:

Adherence can be defined as the extent to which patients follow the instructions they are given for prescribed treatments. Highly active antiretroviral therapy (HAART) has demonstrated remarkable success in reducing morbidity, mortality, and healthcare costs for HIV-positive people. The lifesaving benefits of HAART are not achieved if patients do not take them as prescribed. Behavioral interventions are intended to assist patients with this task.

Стилі APA, Harvard, Vancouver, ISO та ін.

Tao, Zhuang, Xiaojie Huang, Ying LIU, Jipeng Dong, Yang Zhao, and Jian Wang. Adherence to Antiretroviral Therapy of HIV/AIDS patients in China: A system review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2020. http://dx.doi.org/10.37766/inplasy2020.6.0044.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Yuan, Bo, Wei Cao, Xieyu Zhang, Yue Yang, and Jiahe Zhao. Telemedicine effect on rheumatoid arthritis : A protocol for a systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0109.

Повний текст джерела

Анотація:

Review question / Objective: The role of telemedicine has been highlighted by researchers in many fields as a potential advantage for improving quality of life, increasing patient adherence, and alleviating patient concerns. Telemedicine is patient-acceptable with high satisfaction rates in patients with rheumatoid arthritis (RA). However, there is a lack of consistent results among important indicators regarding RA, such as patient pain assessment and health-related quality of life. Thus, we plan to perform a systematic review and meta-analysis to assess the effect of telemedicine on patients with RA. Information sources: PubMed, Embase, and Cochrane Library databases.

Стилі APA, Harvard, Vancouver, ISO та ін.

Steinmann, Peter, and Andrew D. Oxman. Do reminder systems improve the effectiveness of tuberculosis diagnosis and management? SUPPORT, 2016. http://dx.doi.org/10.30846/160814.

Повний текст джерела

Анотація:

Adherence to treatment, and diagnostic and treatment appointments is essential for effective tuberculosis (TB) detection and treatment. Reminder systems are sometimes used to remind patients to take their TB medication or to attend appointments (pre-appointment reminders), or to contact patients who have missed an appointment (default reminders).

Стилі APA, Harvard, Vancouver, ISO та ін.

Oh, SangHyeon, Seoyong Choi, and Jee-Eun Chung. Comparative efficacy and safety of reduced dose of DOACs in patients with atrial fibrillation. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0073.

Повний текст джерела

Анотація:

Review question / Objective: To compare the risk of stroke/systemic embolism (S/SE), mortality and bleeding in AF patients with reduced-dose DOACs. Rationale: Although each DOAC has its dose reduction criteria, many physicians still prefer to prescribe the reduced-dose DOACs, regardless of label adherence. However, inappropriate administration of DOACs is an important clinical problem because patients may not benefit from the recommended DOAC dose to prevent stroke and systemic embolism. Therefore, this study aims to investigate the risk of stroke/systemic embolism (S/SE) and mortality in AF patients with reduced-dose DOACs. Condition being studied: Adult patients with AF taking DOACs or Warfarin.

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!